Leah Hubbard

Program Director, Translational Research Program

Division of Cancer Treatment and Diagnosis

Translational Research Program

Portfolios: Brain Cancer, Head and Neck Cancer

Leah Hubbard, PhD is a Program Director in the Translational Research Program in the Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI). Dr. Hubbard has been a member of the Translational Research Program since 2013 and manages Specialized Programs of Research Excellence (SPOREs) in brain cancer. Dr. Hubbard also participates in a number of NCI initiatives, including the U19 Glioblastoma Therapeutics Network RFA. Dr. Hubbard received her PhD in Immunology, and she continued her postdoctoral training at the National Institute of Allergy and Infectious Diseases at NIH. Dr. Hubbard's research training is in the area of innate immunity, with specific expertise in lung macrophage function and host defense; eicosanoid signaling; and syngeneic mouse modeling.